Limited funding can adversely affect the quality of epidemiological research. Insufficient funds may lead to smaller sample sizes, reducing the statistical power of studies and increasing the risk of Type II errors. It can also limit the ability to use advanced technologies and methodologies, compromising the robustness of findings. Furthermore, funding constraints can lead to shorter study durations, which may not capture long-term health outcomes effectively.
